News

Long QT syndrome (LQTS), caused by an ion channel-related gene mutation, is a malignant heart disease with a clinical course of a high incidence of ventricular fibrillation and sudden cardiac death in the young.

The American College of Cardiology announced a collaboration with the Society for Vascular Surgery focused on a single vascular registry to improve outcomes and care for patients with vascular disease.

The Trump Administration filed its brief in the health care lawsuit before the Supreme Court, asking the justices to strike down the entirety of the Affordable Care Act. The American Heart Association, the world’s leading voluntary organization focused on heart and brain health, released the following statement in opposition to the brief:

There is no survival advantage with invasive coronary revascularization over medical therapy in patients with stable ischemic heart disease, but revascularization does reduce the incidence of unstable angina and provides greater symptom relief, according to the results of a new study-level meta-analysis.

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA) for the company’s HeartStart FR3 [1] and HeartStart FRx [2] automated external defibrillators (AEDs), and their supporting accessories, including batteries […]

Among patients with venous outflow obstruction, a self-expanding venous stent system was safe and effective, researchers reported at the virtual Charing Cross Symposium.

The American Heart Association (AHA), the world’s leading nonprofit organization focused on heart and brain health for all, launches the Bernard J. Tyson Impact Fund to invest in solutions designed to break down the social and economic barriers to health equity.

BIOTRONIK has today announced its commitment to giving physicians additional tools to pace in the His-Bundle, coinciding with the launch of its His-Bundle Pacing (HBP) tools in a limited number of centers starting now with a full launch later in 2020.

CardioFocus, Inc. today announced that the first U.S. patients have been treated commercially with the recently-approved HeartLight® X3 Endoscopic Ablation System.